Agenus (AGEN) Reports Q4 Loss, Tops Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of -9.09% and 59.25%, respectively, for the quarter ended December 2022. Do the…
Echtzeit-Aktienkurs Agenus Inc.
Bid:
Ask:
Nachrichten zur Agenus Inc. Aktie
Agenus GAAP EPS of -$0.24 misses by $0.02, revenue of $28.39M beats by $10.56M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AGENUS INC For: Mar 14
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives
LEXINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with a pipeline…
Agenus Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Agenus (Nasdaq: AGEN), an immuno-oncology company with a pipeline of…
Form 8-K AGENUS INC For: Dec 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
LEXINGTON, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…
Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer
· The trial will be sponsored by The University of Kansas Cancer Center and led by Dr. Anup Kasi, a…
Why Shares of Agenus Rose 12.5% on Friday
Agenus presented data this week on a combination therapy....…
Form 8-K AGENUS INC For: Nov 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Hubro Therapeutics buys vaccine adjuvant from Targovax
Norwegian biotech company Targovax is in full swing with preparations for phase II studies with the drug candidate ONCOS-102. Following…
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
LEXINGTON, Mass., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with a broad pipeline…
Agenus spikes on Phase 1 data for cancer candidates
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus (AGEN) Q3 2022 Earnings Call Transcript
AGEN earnings call for the period ending September 30, 2022....…
Form 10-Q AGENUS INC For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know
Agenus (AGEN) closed the most recent trading day at $2.61, moving -1.14% from the previous trading session....…
Agenus (AGEN) Outpaces Stock Market Gains: What You Should Know
Agenus (AGEN) closed at $2.72 in the latest trading session, marking a +1.49% move from the prior day....…
VBI Vaccine (VBIV) Inks Deal With Agenus for Brain Cancer Study
VBI Vaccines (VBIV) enters into a partnership with Agenus to conduct a study evaluating the formers VBI-1901 in combination with…
Agenus (AGEN) Dips More Than Broader Markets: What You Should Know
Agenus (AGEN) closed at $2.65 in the latest trading session, marking a -1.12% move from the prior day....…
Why Agenus Stock Rose 18.4% on Thursday
The companys shares climbed with help from insider buying....…